Gelatt and Gelatt (2011) mentioned that cataract surgery in both human and animal ophthalmology continues to be identified with the specialty and undoubtedly is the most important intraocular surgery performed in the dog.
Glover and Constantinescu (1997) noted that the advent of phacoemulsification lens extraction and artificial intraocular lens (IOL) implantation offers a favourable success rate; however, many post-operative complications reduces the success rate of this procedure.
Postoperative complications
Miosis
Postoperative miosis occurred on day 1, postoperatively in 83.33% (n=5/6) eyes of group I, which subsided and persisted only in 33.33% (n=2/6) on day 3, postoperatively. Complete absence of miosis was observed on day 7, 15 and 30, postoperatively. In group-II eyes, occurrence of miosis was recorded as 100% (n=6/6) on day 1. This was significantly (p<0.05) reduced in 33.33% (n=2/6) eyes on day 3. On subsequent postoperative days miosis was not observed in any of the eyes. Group-III revealed presence of miosis in 83.33% (n=5/6) on day 1. On day 3, miosis subsided and observed in 33.33% (n=2/6) eyes. However, on day 7, miosis remained only in 16.66% (n=1/6). After day 7 postoperative, none of the eyes showed miosis. Group-IV showed miosis in 83.33% (n=5/6) eyes on day 1 postoperatively. On day 3 postoperative day, miosis was noted in 50.00% (n=3/6) eyes. From day 7 onwards, miosis was not observed in any of the cases. Findings of this study concurred with findings of
Kumar (2008), who reported mild to moderate miosis on day 1 and 3, postoperatively and there after a declining trend on subsequent postoperative days. In the current study, occurrence of postoperative miosis may be attributed to the prolonged duration of phaco-fragmentation procedure as well as IOL implantation, which might have resulted in an intense postoperative iridocyclitis with uncontrollable miosis as suggested by
Gelatt and Gelatt (2011). Postoperative miosis was managed by instillation of mydriatic drugs, as prescribed by
Gelatt and Wilkie (2011).
Aqueous flare
The postoperative aqueous flare in group-I was observed on day 1 in 66.66% (n=4/6) eyes. Statistically non-significant increased aqueous flare was observed on day 3 (Fig 1) in 83.33% (n=5/6) eyes. Thereafter, a declining trend ensued, resulting in observation of flare in 50.00% (n=3/6) eyes on day 7, 50.00% (n=3/6) eyes on day 15 (Fig 2) and 16.66% (n=1/6) eyes on day 30 postoperatively. In group-II, aqueous flare on day 1, postoperatively, was found in 66.66% (n=4/6) eyes. Non-significant increased aqueous flare in 83.33% (n=5/6) eyes was recorded on day 3. Thereafter, from day 7, gradual decline was observed in 83.33% (n=5/6) eyes. On day 15 and 30 a reducing trend in aqueous flare was observed in 50.00% (n=3/6) eyes and 33.33% (n=2/6), respectively, which differed significantly (p<0.05) than score on day 3, postoperatively. The data of group-III revealed, incidence of aqueous flare as 66.66% (n=4/6) on day 1, which increased to 100.00% (n=6/6) eyes on day 3, although it differed non significantly. Statistically non-significant decline was observed on day 7 in 50.00%, (n=3/6). Aqueous flare values further declined on day 15 and 30 postoperatively and reduced significantly (p<0.05) than day 3 values. Evaluation of aqueous flare data of group-IV indicated significantly (p<0.05) higher scores on day 1, 3, 7 and 15 compared to scores at day 30, postoperatively. The results of current study are in agreement with
Yi et al., (2006), who reported observation of flare up to day 14 and complete absence thereafter.
Kalaka et al., (2017) also noticed regression of clinical signs of aqueous flare after 3 to 7 days post-surgery with treatment of topical corticosteroids and antibiotics.
Honsho et al., (2007) evaluated aqueous humour transparency and flare and reported that the flare started immediately at the end of the surgical procedures and was moderate to severe in both eyes. Despite pre and postoperative anti-inflammatory therapy, moderate to severe flare was observed, as also encountered in current study. This might be due to the dilatation of vessels in the iris and ciliary body and from an increased permeability of the blood-aqueous barrier mediated, largely, by the release of prostaglandins.
Hyphema
In group-I, postoperative hyphema was observed in 33.33% (n=2/6) eyes on day 1 till day 3 and decreased to 00.00% (n=0/6) on day 7 onwards. Similarly, 16.66% (n=1/6) eyes of group-II showed hyphema on day 1 and 3, which later decreased to 00.00% (n=0/6) on day 7. On subsequent observation days, no hyphema was observed in any of the eyes. In group-III, 16.66% (n=1/6) eyes operated showed hyphema on day 1 (Fig 3). On the day 3 observations, none of the eyes showed hyphema and similar results were obtained on subsequent days of observation. Hyphema was observed in 33.33% (n=2/6) eyes on day 1 in group-IV. On day 3 observation 16.66% (n=1/6) eyes showed hyphema. A complete regression of hyphema was observed on day 7 and on subsequent days, it was not observed in any of the eyes.
Gelatt and Gelatt (2011) stated that hyphema or blood in the anterior chamber may be an early or late complication of cataract extractions and lensectomy.
Klein et al., (2011) also observed hyphema in 22 eyes (12.3%) and reported intraocular haemorrhage occurrence at a median of 10 days (0-513) postoperatively. Current study findings were in agreement with
Guimaraes et al., (2017) that reported non-significant difference in the incidence of hyphema between hydrophilic and hydrophobic IOL implanted groups. The cause of postoperative hyphema in the current study was self-inflicted trauma and coinciding uveitis as suggested by
Wilkie and Colitz (2007).
Corneal opacity
The postoperative corneal opacity recorded for group-I was moderate to mild with an average score of 1.67±0.21 on day 1 (Fig 4). Complete absence of corneal opacity was observed on Dog 6 from day 7 onwards (Fig 5), in Dog 5 on day 15 onwards and in Dog 2 day 30 onwards, postoperatively. All the other dogs showed moderate to mild progressive corneal opacities, which failed to respond to treatment protocols. All the dogs in group-II exhibited corneal opacity on day 1 day with a score of 1.83±0.17. Statistically non-significant difference was observed on scores of days 1, 3, 7, 15 and 30. However, complete absence of corneal opacity was observed in Dog 1 and Dog 4 on day 7 and in D6 on day 15 onwards, postoperatively. Remaining dogs showed severe to moderate progressive corneal opacities, which failed to respond to treatment protocols. In group-III, corneal opacity scores were 1.50±0.22 with mild to moderate opacity in all the eyes with continuation on day 3. On day 7, Dog 1, Dog 3, Dog 4 and Dog 6 eyes showed absence of corneal opacity, whereas D2 and D5 showed severe corneal opacity with a score of 1.00±0.63. This trend continued and on 15 and 30 postoperative days and non-significant improvement was observed in Dog 2 and Dog 5. Mild to moderate corneal opacity was observed in all the dogs of group-IV with a score of 1.67±0.21. This persisted on day 3 postoperatively. On day 7, diminished corneal opacity was observed in D2, D3 and D6 and severe to moderate corneal opacity was observed in rest of the dogs with score of 1.17±0.54. This trend continued day 15 and 30 postoperative days.
The results and trends observed in this study concurred with findings of
Sooryadas (2010), who observed significant reduction of corneal transparency on the first postoperative day which remained so until day 7. Significant gain in the transparency was observed on the day 14 onwards.
Ahmad et al., (2017) found that corneal opacity and uveitis were the most common post-operative complication after phacoemulsification It was suggested that trauma caused to the eyes by procedure, could have damaged the corneal endothelium and resulted in severe corneal opacity and corneal oedema. This may also be a reason of corneal opacity in the present study.
Posterior capsular opacification
None of the dogs showed incidence of PCO up to day 90 of observation. The results are in accordance with
Ahmad (2016) who did not find any incidence of PCO after phacoemulsification and IOL implantation. However, earlier workers
viz.
Kalaka et al., (2017) reported incidence of PCO in 9 (37.5%) out of 24 cases, after 80 days post operatively.